surrounded by like-minded people in the same relative age range,” David Gildea, principal of Bushrod Investments, said in a statement. Developers are close to finalizing a deal with an operator ...
The Central Bank has fined the Irish unit of US investment group Cantor Fitzgerald €452,790 for failing to report suspicious transactions that may have indicated market abuse. Between March 2017 ...
The Central Bank said Cantor failed on a number of occasions to report identified suspicious transactions that may have indicated market abuse. The Central Bank of Ireland fined Cantor Fitzgerald ...
will participate in a fireside chat at Cantor Fitzgerald Global Technology Conference on Tuesday, March 11, 2025 at 1:00 p.m. EDT. A live webcast of the session will be available in the Investor ...
Brice Hill, CFO of Applied Materials, will participate in a fireside chat at the Cantor Fitzgerald Conference on March 12. Applied Materials, Inc. announced that Brice Hill, Senior Vice President ...
On Wednesday, Cantor Fitzgerald reaffirmed its confidence in Harmony Biosciences Holdings Inc. (NASDAQ:HRMY), maintaining an Overweight rating with a steady price target of $54.00. The firm's ...
Cantor Fitzgerald sees a significant event for NVIDIAthe expected Blackwell product release in the July quarter. Analysts think Blackwell might be a significant trigger, maybe influencing market ...
SANTA CLARA, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that Brice Hill, Senior Vice President and CFO, will participate in a fireside chat at the Cantor ...
One of the bright spots in attendance for the Florida State Seminoles is kicker Ryan Fitzgerald, who delivered a flawless 13-for-13 record on field goal attempts and was five-for-five from 50 ...
On Tuesday, Cantor Fitzgerald began coverage of Metsera Inc (NASDAQ:MTSR) with an Overweight rating, highlighting the biotech company’s potential in the obesity drug market. The firm’s analyst praised ...
On Tuesday, Cantor Fitzgerald began coverage of Metsera Inc (NASDAQ:MTSR) with an Overweight rating, highlighting the biotech company's potential in the obesity drug market. The firm's analyst ...